India is currently facing a significant public health challenge characterised by the rising rates of obesity among its youth. Recent statistics illustrate that nearly twenty-five million children and adolescents in the country are classified as obese....
Eli Lilly की नई दवा भारत में हुई लॉन्च
हाल ही में वैश्विक दवा कंपनी एली लिली (Eli Lilly) ने भारत में अपनी बहुप्रतीक्षित दवा 'मौनजारो' (Mounjaro) को आधिकारिक तौर पर लॉन्च कर दिया है। यह दवा विशेष...
The Government of India has published a comprehensive advisory regarding GLP-1 medications, emphasizing their increasing application in treating type 2 diabetes and obesity, while...
India is currently grappling with a significant obesity crisis, with statistics indicating that one in four Indians is classified as overweight. This troubling trend...
Medications initially developed for managing diabetes and obesity are broadening their therapeutic applications. Recently, treatments based on the hormone GLP-1 have demonstrated benefits not...
The Indian healthcare market is bracing for a significant change as more than twenty generic variants of semaglutide, a highly sought-after drug for obesity...
India is developing its first National Obesity Guidelines after Prime Minister Narendra Modi’s Independence Day warning that obesity has become a “silent crisis” for...
American कंपनी Eli Lilly ने भारत में वजन घटाने की दवा Mounjaro लॉन्च की, जिसकी कीमत₹14,000 से ₹17,500 प्रति माह होगी। यह दवा Blood Sugar कंट्रोल और भूख कम करने में मदद करतीहै। Obesity और Diabetes से जूझ रहे लोगों के लिए यह एक क्रांतिकारी कदम है।
Eli Lilly Weight-Loss Drug अब भारत में...
